Health and Pharmaceuticals

Capella eyes $1bn RNS hospital

Capella Capital is the latest party to emerge as a suitor for the Royal North Shore hospital in Sydney.

Johnson & Johnson to buy Alios BioPharma

by AAP
Signs all-cash to buy private health care group for $US1.75bn.

The start-up giving Telstra's HealthEngine a run for its money

Just two years ago Benjamin Hurst was living in New York taking creative writing classes. Now he's CEO of a medical start-up that's scoring big wins in Australia.

DataRoom AM: Medibank's IPO injection

The health insurer has been valued by investment banks at up to $5.7bn, while law firm Spruson & Ferguson is pressing ahead with its own IPO.

How Medibank customers will make or break its float

The strategy put in play by George Savvides and Mathias Cormann requires a few key ingredients to ensure its success.

Medibank receives $5bn price tag

Medibank Private valued at as much as $5.7bn by investment bank analysts.

Medibank's float will be a critical test for the IPO market

The promotors of the IPO will be keeping a close eye on offshore developments in the lead up to the planned December listing.

Royal Bank of Scotland chair moves to GSK

by AFP
Philip Hampton's appointment follows a Chinese corruption scandal at the drugs firm.

Soul Patts likes look of Regis

Washington H. Soul Pattinson is the latest group to emerge as a future shareholder of aged care company.

RBS chair moves to GSK

by AAP
Philip Hampton to take up chair of drugs firm.

Ingenia oversubscribed for institutional offering

Retirement village operator believed to be at least twice oversubscribed on strong local, offshore demand.

Medibank urged to 'cost out' after float

Analysts say cost-cutting, business simplification will be needed to drive growth.

Primary wants health insurance deregulated

Primary could lure its newly-acquired pool of health-insurance members to be customers of its health services, analysts suggest.

Pharmacy protection should be lifted: Harper review

The draft Harper report recommends scrapping restrictions on the ownership and location of pharmacies.

Regis founders to retain 54.5% stake after IPO

Regis priced its shares at $3.65 each and the firm will have a market value of $1.1 billion on listing.

Primary buys private health insurer for $18m

Health provider says move into the insurance market will provide a 'natural extension' of its services.

Regis to be priced in top half of range

Current owners of the aged care provider, valued at around $1bn, may sell more shares than initially planned in the IPO.

Top Ramsay Health shareholder to sell 2.2% stake

Paul Ramsay Holdings will sell over 4 million shares in the hospital operator, worth around $224.4m, through a book build tonight.

Regis plans to double in size in 5 years

The aged care provider is meeting with fund managers as it prepares to raise at least $407m from an IPO on Monday.

Cabinet okays competitiveness agenda

Govt to support strongest parts of the economy, industry to back apprentice training.